HopeStage
Back to all studies
CompletedNCT04542642

A Remote, Decentralized Addiction Study to Evaluate Patient Engagement With a Game-Based Digital Therapeutic

Device studyAges 18–60United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 60 years.

Listed locations
New York and 1 more locationSee all locations and recruitment
Study clarity

Study information

Study start dateStarted: May 19, 2021
Recruitment status
Completed
Enrollment listed in the registry
52
Sponsor
Pear Therapeutics, Inc.
Sponsor type
Biotech company
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 60 Years
Official registry ID
NCT04542642
Official title
Show the full official title

A Randomized, Controlled, Open-Label, Decentralized Study, to Evaluate Patient Engagement With PEAR-008, a Game-Based Digital Therapeutic for the Treatment of Opioid Use Disorder

Looking for a study you can join?

Explore recruiting studies

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Completed

New York · Gig Harbor

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Pear Therapeutics, Inc.

Who was this study for?

Listed age limits: 18 years to 60 years.

Want to explore more studies?

Explore studies